Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Victoria Shi
Observed names:
V Shi,
V. Shi
Institutions:
Johns Hopkins University,
Johns Hopkins Medicine,
National Institute of Allergy and Infectious Diseases
Observed institutions:
Johns Hopkins University,
Washington University in St. Louis,
Johns Hopkins Medicine,
University of Washington Medical Center,
Enzon Pharmaceuticals (United States),
National Institute of Allergy and Infectious Diseases
show all 6
ORCID:
0000-0002-5235-2425
Observed ORCID:
0000-0002-5235-2425
OpenAlex ID:
A5081488428
Down-modulation of cancer targets using locked nucleic acid (LNA)-based antisense oligonucleotides without transfection
2010
·
Y Zhang
, Z Qu
, et al.
·
Gene Therapy
·
81
PDF
Reduced Expression of the Androgen Receptor by Third Generation of Antisense Shows Antitumor Activity in Models of Prostate Cancer
2011
·
Yixian Zhang
, Stephen Castaneda
, et al.
·
Molecular Cancer Therapeutics
·
48
PDF
SCCA1/SERPINB3 suppresses antitumor immunity and blunts therapy-induced T cell responses via STAT-dependent chemokine production
2023
·
Liyun Chen
, Victoria Shi
, et al.
·
Journal of Clinical Investigation
·
45
PDF
Downregulation of HER3 by a Novel Antisense Oligonucleotide, EZN-3920, Improves the Antitumor Activity of EGFR and HER2 Tyrosine Kinase Inhibitors in Animal Models
2013
·
Yaming Wu
, Yixian Zhang
, et al.
·
Molecular Cancer Therapeutics
·
40
SERPINB3 (SCCA1) inhibits cathepsin L and lysoptosis, protecting cervical cancer cells from chemoradiation
2022
·
Songyan Wang
, Cliff J. Luke
, et al.
·
Communications Biology
·
38
PDF
Accuracy of surveillance serum squamous cell carcinoma antigen for cervical cancer recurrence after definitive chemoradiation
2024
·
Victoria Shi
, Surbhi Grover
, et al.
·
International Journal of Gynecological Cancer
·
13
Characterization of elite controllers with an undetectable intact HIV DNA reservoir
2026
·
Jana Blazkova
, Brooke D. Kennedy
, et al.
·
Journal of Clinical Investigation
·
2
PDF
Abstract 2426: SERPINB3 promotes radiation resistance in cervical cancer by inhibiting lysosome-mediated cell death
2020
·
Songyan Wang
, Clifford Luke
, et al.
·
Cancer Research
·
2
Abstract 2374: Squamous cell carcinoma antigen regulates macrophage polarization, contributing to inhibition of T cell activity in cervical cancer chemo-radiotherapy
2023
·
Liyun Chen
, Victoria Shi
, et al.
·
Cancer Research
·
1
Serum SCCA as an Early Indicator of Recurrence in Cervical Cancer
2021
·
V. Shi
, Y. Huang
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
·
1
PDF
Abstract 2680: SERPINB3 promotes myeloid cell chemotaxis and associated chemokine production in cervical cancer
2021
·
Liyun Chen
, Songyan Wang
, et al.
·
Cancer Research
·
1
307 An antisense molecule to HER3 sustains growth inhibitory effects in gefitinib resistant cells that are independent of MET overexpression
2010
·
Z. Qu
, Y. Wu
, et al.
·
European Journal of Cancer Supplements
·
1
53 Down regulation of beta-catenin by a locked nucleic acid oligonucleotide antagonist inhibits tumor growth in experimental models of human cancer
2010
·
M. Dumble
, Y. Zhang
, et al.
·
European Journal of Cancer Supplements
·
1
Surveillance Imaging Findings of Lung Cancer Recurrence after Definitive Therapy
2026
·
Raheel Anwar
, Andrea Brown
, et al.
·
Radiographics
Abstract 4696: Targeting CSF1R+ macrophages to synergize immune checkpoint therapy in SCCA-mediated radioresistant cervical cancer
2025
·
Liyun Chen
, Eric Liu
, et al.
·
Cancer Research
Abstract 6873: Prognostic impact of squamous cell carcinoma antigen as a mediator of anti-inflammatory macrophage polarization in tumor microenvironment
2024
·
Liyun Chen
, Victoria Shi
, et al.
·
Cancer Research
Data from Downregulation of HER3 by a Novel Antisense Oligonucleotide, EZN-3920, Improves the Antitumor Activity of EGFR and HER2 Tyrosine Kinase Inhibitors in Animal Models
2023
·
Yaming Wu
, Yixian Zhang
, et al.
Abstract 212: Squamous cell carcinoma antigen counteracts the radiation-induced antitumor response by driving an immune evasion phenotype through STAT signaling
2022
·
Liyun Chen
, Victoria Shi
, et al.
·
Cancer Research
Abstract 5647: Marked sensitivity to mRNA targeting by LNA antisense in tumor cells without a delivery system: Lessons learned and potential translation to the clinic
2012
·
Yixian Zhang
, Melissa Dumble
, et al.
·
Cancer Research
Abstract 232: Targeting HER3 mRNA by a locked nucleic antisense molecule enhances the antitumor activity of gefitinib in vivo
2011
·
Yaming Wu
, Maoliang Wang
, et al.
·
Cancer Research
Abstract 601: In vitro and in vivo inhibition of β-catenin by two novel β-catenin RNA antagonists, EZN-3889 and 3892
2010
·
Yixian Zhang
, Steven Kim
, et al.
·
Cancer Research
Abstract 600: Targeting the hedgehog pathway by LNA (locked nucleic acid) oligonucleotide-based GLI2 RNA antagonists, EZN-4482 and EZN-4496, in vitro and in vivo
2010
·
Zhengxing Qu
, Yixian Zhang
, et al.
·
Cancer Research
Abstract C141: In vitro and in vivo characterization of two novel β-catenin RNA antagonists, EZN-3889 and 3892
2009
·
Yixian Zhang
, Puja Sapra
, et al.
·
Molecular Cancer Therapeutics
Abstract C148: LNA (locked nucleic acid)-based RNA antagonists mediate target mRNA silencing without transfection by simple addition to cell culture media
2009
·
Yixian Zhang
, Zhengxing Qu
, et al.
·
Molecular Cancer Therapeutics
Show more works
View as search
Works count:
24
Citation count:
274
H-index:
6
I10-index:
6
Year
Topic
Type